Home > Insider Trading > Filing (0000899243-22-001654)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1827087	Vigil Neuroscience Inc.	VIGL	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1759241	Atlas Venture Opportunity Fund I, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1780065	Atlas Venture Associates Opportunity I, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1780066	Atlas Venture Associates Opportunity I, Llc	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1812049	Atlas Venture Fund Xii, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1845871	Atlas Venture Associates Xii, Llc	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1845875	Atlas Venture Associates Xii, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-01-11	2,831,520	$0.00	4,273,896	No	4	C	Indirect	By Atlas Venture Fund XII, L.P.
Common Stock	Acquisiton	2022-01-11	1,027,978	$0.00	1,027,978	No	4	C	Indirect	By Atlas Venture Opportunity Fund I, L.P.
Common Stock	Acquisiton	2022-01-11	535,000	$14.00	4,808,896	No	4	P	Indirect	By Atlas Venture Fund XII, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Atlas Venture Fund XII, L.P.
No	4	C	Indirect	By Atlas Venture Opportunity Fund I, L.P.
No	4	P	Indirect	By Atlas Venture Fund XII, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2022-01-11	7,852,374	$0.00	2,831,520	$0.00
Common Stock	Series B Preferred Stock	Disposition	2022-01-11	2,850,789	$0.00	1,027,978	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
These shares are held directly by Atlas Venture Fund XII, L.P. ("Atlas Venture Fund XII"). The general partner of Atlas Venture Fund XII is Atlas Venture Associates XII, L.P. ("AVA XII LP"). Atlas Venture Associates XII, LLC ("AVA XII LLC") is the general partner of AVA XII LP. Each of AVA XII LP and AVA XII LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund XII, except to the extent of its pecuniary interest therein, if any.
These shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Opportunity Fund I, except to the extent of its pecuniary interest therein, if any.
On January 11, 2022, Atlas Venture Fund XII purchased 535,000 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.